We are live on ! Find out more
IONS icon

Ionis Pharmaceuticals
IONS

173 hedge funds and large institutions have $2.84B invested in Ionis Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 173 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more call options, than puts

Call options by funds: $36M | Put options by funds: $29.5M

Holders
173
Holders Change
+173
Holders Change %
–
% of All Funds
5.65%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
173
Increased
–
Reduced
–
Closed
–
Calls
$36M
Puts
$29.5M
Net Calls
+$6.51M
Net Calls Change
+$6.51M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$436M +$345M +16,222,264 New
Artisan Partners
2
Artisan Partners
Wisconsin
$246M +$195M +9,164,743 New
BB
3
BB Biotech
Switzerland
$209M +$165M +7,769,172 New
ClearBridge Investments
4
ClearBridge Investments
New York
$183M +$145M +6,822,525 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$180M +$143M +6,701,309 New
BNP Paribas Financial Markets
6
BNP Paribas Financial Markets
France
$176M +$22.1M +1,039,563 New
WRF
7
Waddell & Reed Financial
Kansas
$104M +$82.4M +3,877,300 New
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$103M +$81.6M +3,835,755 New
BFA
9
BlackRock Fund Advisors
California
$98.8M +$78.2M +3,675,568 New
BIT
10
BlackRock Institutional Trust
California
$87.4M +$69.2M +3,253,778 New
State Street
11
State Street
Massachusetts
$72.8M +$57.6M +2,710,419 New
Jennison Associates
12
Jennison Associates
New York
$60.3M +$47.7M +2,245,501 New
PA
13
Pinnacle Associates
New York
$56.9M +$45.1M +2,119,363 New
Lord, Abbett & Co
14
Lord, Abbett & Co
New Jersey
$56.6M +$44.8M +2,108,266 New
TAM
15
Tocqueville Asset Management
New York
$52.2M +$41.3M +1,941,753 New
Franklin Resources
16
Franklin Resources
California
$49.2M +$38.9M +1,831,340 New
Northern Trust
17
Northern Trust
Illinois
$44M +$34.8M +1,638,621 New
BA
18
BlackRock Advisors
Delaware
$41.2M +$32.6M +1,534,031 New
AllianceBernstein
19
AllianceBernstein
Tennessee
$38.9M +$30.8M +1,446,363 New
Wells Fargo
20
Wells Fargo
California
$32.7M +$25.9M +1,217,045 New
Allianz Asset Management
21
Allianz Asset Management
Germany
$29.5M +$23.3M +1,097,727 New
GIM
22
Granahan Investment Management
Massachusetts
$24.5M +$19.4M +911,189 New
Millennium Management
23
Millennium Management
New York
$21.9M +$17.3M +814,318 New
DY
24
Dowling & Yahnke
California
$20.8M +$16.5M +775,798 New
PAM
25
Panagora Asset Management
Massachusetts
$20.2M +$16M +751,921 New
1
2 3 4 5

IONS Hedge Fund Activity: Q2 2013 in Review

173 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Ionis Pharmaceuticals (IONS) for Q2 2013, worth a combined $2.84B.

Buyers outnumbered sellers: 173 funds opened new IONS positions and 0 closed out — a net gain of 173 holders — while 0 added to existing stakes and 0 trimmed.

  • 173 institutional investors held Ionis Pharmaceuticals (IONS) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $2.84B of Ionis Pharmaceuticals stock for Q2 2013.
  • 173 funds opened new Ionis Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +173 holders.

Based on aggregated 13F filings for Q2 2013.